SCHEMBL1079995

SCHEMBL1079995

NC(=O)c1c[nH]c(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
PARP1 P09874 3/20 0.46
CHEK2 O96017 3/20 0.45
CYP1A2 P05177 2/20 0.45
DHODH Q02127 3/20 0.44
KDM4E B2RXH2 3/20 0.43
PIN1 Q13526 3/20 0.42
MAPK1 P28482 3/20 0.42
CASP1 P29466 2/20 0.42
CYP2C19 P33261 1/20 0.42
MAP2K3 P46734 1/20 0.41
IKBKB O14920 2/20 0.41
CHUK O15111 1/20 0.41
BCAT2 O15382 1/20 0.40
CDC7 O00311 1/20 0.40
PLK4 O00444 1/20 0.40
CHEK1 O14757 1/20 0.40
AURKA O14965 1/20 0.40
MAPK13 O15264 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1080850 0.87 PIN1 (0.47) ALDH1A1CYP1A2DHODHKDM4EPIN1
Hydrochloric Acid SCHEMBL6861539 0.85 PIN1 (0.46) ALDH1A1CYP1A2DHODHKDM4EPIN1
SCHEMBL811735 0.85 MAPT (0.46) ALDH1A1CYP1A2KDM4EPIN1MAPK1
SCHEMBL30014280 0.84 CCNC (0.51) PARP1CHEK2MAP2K3CDC7PLK4
SCHEMBL6861535 0.84 PIN1 (0.41) ALDH1A1PARP1CYP1A2DHODHPIN1
SCHEMBL7231545 0.84 PRSS1 (0.44) ALDH1A1PARP1CYP1A2KDM4E
SCHEMBL3735844 0.84 DCUN1D1 (0.39) ALDH1A1PARP1CHEK2CYP1A2KDM4E
SCHEMBL19734173 0.83 MEN1 (0.47) ALDH1A1CYP1A2KDM4EPIN1CDC7
Propionamide SCHEMBL27851687 0.82 KDM4E (0.43) ALDH1A1PARP1CHEK2CYP1A2KDM4E
SCHEMBL1078329 0.82 CHEK2 (0.48) ALDH1A1PARP1CHEK2DHODHIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011005052-A2 NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME GREEN GROSS CORPORATION (KR) 2011-01-13 WO claimed
US-20050256167-A1 Preparation and use of imidazole derivatives for treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2005-11-17 US disclosed
US-6960601-B2 Preparation and use of imidazole derivatives for treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2005-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256167-A1 Preparation and use of imidazole derivatives for treatment of obesity GPR119, GIPR, PGC ALDH1A1 2202/4885PARP1 4121/4885CHEK2 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.